Withdrawal of Byretol, or rivaroxaban, needs to be considered if GI bleeding occurs. Give counterpart treatment such as omeprazole for acid suppression and endoscopic hemostasis Rivaroxaban is a newer anticoagulant with a lower risk of bleeding compared to warfarin, but there is still a risk of bleeding. If gastrointestinal bleeding is caused by the drug, it is necessary to consider stopping or changing the drug. In case of bleeding, medication can be prescribed to inhibit gastric acid secretion, such as rabeprazole, omeprazole, etc. In serious cases, if medication is ineffective in stopping bleeding, endoscopic hemostasis can be considered, and in individual patients with severe gastrointestinal ulcers, even surgical hemostasis is needed. In most patients, gastrointestinal bleeding can be effectively controlled by stopping medication and treatments such as acid suppression and gastric protection. If bleeding persists, patients should consult the doctor as soon as possible and follow the doctor’s instructions to avoid accidents due to bleeding.